Skip to main content
Premium Trial:

Request an Annual Quote

Rheonix Gets $500K SBIR Grant

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rheonix has been awarded a $500,000 Small Business Innovation Research Phase II grant to further develop its Chemistry and Reagent Device, or CARD, system for the detection of certain types of water contamination.

The Ithaca, NY- based molecular diagnostics firm said it will use the grant to develop the CARD system for recreational water testing for the presence of fecal indicator bacteria. FIB testing is routinely done for US beaches to ensure the water is not contaminated with potentially pathogenic bacteria, Rheonix said.

The underlying CARD system, it added, also has applications in markets, such as human and veterinary in vitro diagnostics, biopharmaceutical manufacturing, food and beverage manufacturing, food and water safety testing, and homeland security and defense applications.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.